West Pharmaceutical Services Inc (WST)
318.14
-2.74
(-0.85%)
USD |
NYSE |
Nov 22, 15:25
West Pharmaceutical Services Revenue (TTM): 2.876B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.876B |
| June 30, 2024 | 2.877B |
| March 31, 2024 | 2.929B |
| December 31, 2023 | 2.950B |
| September 30, 2023 | 2.926B |
| June 30, 2023 | 2.866B |
| March 31, 2023 | 2.884B |
| December 31, 2022 | 2.887B |
| September 30, 2022 | 2.909B |
| June 30, 2022 | 2.929B |
| March 31, 2022 | 2.881B |
| December 31, 2021 | 2.832B |
| September 30, 2021 | 2.681B |
| June 30, 2021 | 2.522B |
| March 31, 2021 | 2.326B |
| December 31, 2020 | 2.147B |
| September 30, 2020 | 2.037B |
| June 30, 2020 | 1.945B |
| March 31, 2020 | 1.888B |
| December 31, 2019 | 1.840B |
| September 30, 2019 | 1.792B |
| June 30, 2019 | 1.767B |
| March 31, 2019 | 1.745B |
| December 31, 2018 | 1.717B |
| September 30, 2018 | 1.710B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.677B |
| March 31, 2018 | 1.627B |
| December 31, 2017 | 1.599B |
| September 30, 2017 | 1.566B |
| June 30, 2017 | 1.544B |
| March 31, 2017 | 1.535B |
| December 31, 2016 | 1.509B |
| September 30, 2016 | 1.486B |
| June 30, 2016 | 1.454B |
| March 31, 2016 | 1.426B |
| December 31, 2015 | 1.400B |
| September 30, 2015 | 1.390B |
| June 30, 2015 | 1.401B |
| March 31, 2015 | 1.410B |
| December 31, 2014 | 1.421B |
| September 30, 2014 | 1.414B |
| June 30, 2014 | 1.400B |
| March 31, 2014 | 1.376B |
| December 31, 2013 | 1.368B |
| September 30, 2013 | 1.347B |
| June 30, 2013 | 1.309B |
| March 31, 2013 | 1.290B |
| December 31, 2012 | 1.266B |
| September 30, 2012 | 1.240B |
| June 30, 2012 | 1.230B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.840B
Minimum
Dec 2019
2.950B
Maximum
Dec 2023
2.607B
Average
2.871B
Median
Revenue (TTM) Benchmarks
| Repligen Corp | 633.51M |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 38.27M |
| Xtant Medical Holdings Inc | 113.86M |
| Catheter Precision Inc | 0.399M |